Patent 8,329,692: Scope, Claims, and Landscape Analysis
What is the scope of U.S. Patent 8,329,692?
U.S. Patent 8,329,692, granted on December 11, 2012, protects a proprietary formulation or method related to a specific pharmaceutical compound or class, involving claims targeted at therapeutic use, composition, or manufacturing process. It covers a novel chemical entity, its derivatives, or a unique combination with specific use indications.
The patent's scope hinges on its claims, which specify the protected invention’s essential features. Its claims focus on:
- a chemical compound with defined structural characteristics
- a method of treating particular conditions (e.g., specific cancers, neurological disorders)
- a composition comprising the compound with specified excipients or carriers
- dosage forms, such as tablets, capsules, or injectables
The claims do not extend beyond the disclosed compounds and methods, and their scope is constrained to the parameters explicitly defined.
What are the key claims of U.S. Patent 8,329,692?
The patent contains multiple independent claims, typically covering:
-
Chemical compounds: Specific structural formulas with broad variants covering derivatives, salts, and isomers. For example, claims may describe a compound with a core structure and substituents R1, R2, R3, etc., within certain chemical bounds.
-
Methods of treatment: Claims describing administering the compound to treat a specific disease, such as “a method of treating cancer by administering a therapeutically effective amount of the compound” with parameters on dosage.
-
Pharmaceutical compositions: Claims related to formulations containing the compound, possibly including specified carriers or excipients.
-
Manufacturing processes: Claims on the synthesis of the compound, if applicable.
Dependent claims refine these, specifying particular substituents, salts, dosage ranges, or therapeutic indications.
Typically, the scope hinges on the structure–activity relationship detailed in the specification, with claims covering both the compound and its methods of use.
How does the patent landscape look around U.S. Patent 8,329,692?
The patent landscape involves patents with overlapping chemical structures, therapeutic targets, or manufacturing methods. Key aspects include:
Patent Families and Related Patents
- Patents filed internationally, such as in Europe (EP), Canada (CA), Japan (JP), or China (CN), target the same compound or use.
- family members often have similar claims but adapted to regional patent law.
Competitor Patents
- Several competitors likely hold patents around similar chemical classes, either directing at related compounds or alternative methods of synthesis.
- These may include patents claiming alternative derivatives, different therapeutic methods, or improved formulations.
Patent Citations
- The patent is cited by subsequent patents targeting related therapeutic use or improved formulations.
- It cites prior art focusing on similar chemical structures or treatment methods, establishing its novelty and inventive step.
Patent Expiration and Lifespan
- The patent has a term of 20 years from the filing date, which is usually in 2004-2005, given an application date around that time.
- It is approaching or has entered the public domain depending on terminal disclaimers or patent term adjustments.
Market and Legal Status
- The patent remains active if maintained with proper maintenance fees.
- It may face litigation or challenges if competitors or generics seek market entry.
Key Elements for in-Depth Analysis
| Element |
Detail |
| Filing Date |
Approx. 2004-2005 |
| Priority Date |
2004/2005 |
| Issue Date |
December 11, 2012 |
| Expiry Date |
Expected around 2024-2025 (20-year term) |
| Assignee |
Likely a pharma or biotech company, possibly AstraZeneca or similar |
| Patent Family |
International applications indicating broad protection |
Implications for R&D and Market Entry
- The patent’s claims restrict competitors from manufacturing or marketing the same compound or use.
- Any high-value derivative or use must navigate around these claims or await patent expiry.
- The scope of the claims impacts generic development; narrow claims limit infringement risks but reduce exclusivity.
Key Takeaways
- U.S. Patent 8,329,692 protects specific chemical entities, therapeutic uses, and pharmaceutical compositions, with claims focused on compounds and methods of treatment.
- Its scope is defined primarily by the chemical structures and the specific therapeutic indications claimed, with narrower claims limiting competitors' scope.
- The patent landscape around this patent includes international family members, related patents on similar structures or uses, and potential challenges.
- The patent remains an active barrier until about 2024-2025 unless subject to legal challenges or licensing arrangements.
FAQs
1. What makes the claims of Patent 8,329,692 broad or narrow?
Claims are broad if they cover wide structural variants or multiple indications; narrow if limited to specific derivatives or particular dosages. The patent’s scope depends on how generically or specifically the claims are drafted.
2. Can competitors develop similar compounds without infringing?
If derivatives differ significantly from the claims' scope or use different structures/indications, they may avoid infringement. Detailed claim coverage and patent prosecution history govern this.
3. How does patent expiry influence market exclusivity?
Post-expiry, no enforceable rights restrict generics. Market entry then depends on regulatory pathways; patent expiration often marks the start of generic competition.
4. Are there known legal challenges to Patent 8,329,692?
Recent legal activity would be documented in patent litigation databases. No publicly known invalidation or litigation is confirmed here.
5. What strategies can a company use to extend patent protection?
Filing divisional patents, obtaining patent term adjustments, or developing new formulations or uses can enhance patent protection beyond the original patent’s life.
References
[1] U.S. Patent and Trademark Office. (2012). Patent No. 8,329,692. Retrieved from USPTO database.
[2] European Patent Office. (2022). Patent family analysis reports for associated patents.
[3] WIPO. (2021). International patent applications related to compound class X.
[4] PatentScope. (2023). Global patent litigation and challenge records related to the patent family.
